SEARCH
IAGIM - Drug Development Association



IAGIM DRUG and MEDICAL RESEARCH
THE INTERNATIONAL GLIMER I, II & III MS STUDY
(Ongoing 2010 - 2025 Fifteen Year GLIMER I II and III MS Project - Extended 2016)

Prof. J. D. Block - Epidemiologist
(N.I.E.)
Chief Scientist IAGIM Institute and CEO LIGroup

AALTERNATIVE MORE ADVANCED MS Article - www.LocumUSA.com ; Ref: "Article of the Month"
Prof. J. D. Block - Neuro-Immuno-Epidemiologist (N.I.E.)


TO BE PUBLISHED - WATCH THIS SPACE!

Jeremy David Block.
BSc. (Eng.), MSc.(WCU), (Micro/Stats UNISA), D.Pharm (Wits)., PHD (Neuro IAGIM. U.)
Part Four / - 2015/6. - Total Parts: 20 - Pages 110 and growing)


ALTERNATIVE MORE ADVANCED MS Article - www.LocumUSA.com ; Ref: "Article of the Month"
Prof. J. D. Block - Neuro-Immuno-Epidemiologist (N.I.E.)


Background:
J. D. Block served for the duration of the development of COP 1 as a senior medical/pharmaceutical researcher and part of the Teva COP 1 innovative research team in the early nineties that rapidly developed Teva's first MS immuno-modulating drug Glatiramer Acetate (CopaxoneTM). As Chief Scientist as well as Teva's Group Scientific Research Auditor, and by touching each and every part of the Teva's organization and the overall scientific team, Teva rapidly attained New Drug Registration with the FDA under J. D. Block scientific and technical guidance and regulatory department training, GRP, GMP GLP, SOPs, Analytical audits and global organization overview (from early active material synthesis to manufacture and then final freeze dried packaging).


ALTERNATIVE MORE ADVANCED MS Article - www.LocumUSA.com ; Ref: "Article of the Month"
Prof. J. D. Block - Neuro-Immuno-Epidemiologist (N.I.E.)

Epidemiology Note*
ISRAEL Israeli Jews have a prevalence of up to 62 per 100,000, but Christians (35 per 100,000), Moslem Arabs (15), Druze (11), and Bedouins (17) have lower rates (Alter et al 2006). Genetically similar immigrants have half the rate of native-born Jews, suggesting an environmental factor. Other groups also have a significantly lower incidence of multiple sclerosis (Caucasians Hispanics Latino's black African Americans, Asians African Natives, Inuits, SWA bushman, and Romani Gypsies (almost zero)).

ALTERNATIVE MORE ADVANCED MS Article - www.LocumUSA.com ; Ref: "Article of the Month"
Prof. J. D. Block - Neuro-Immuno-Epidemiologist (N.I.E.)

Dictionary of Cancer Terms
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


| MS Global Work Shops |

| Shipping | By FastTrack | Data Protection |
|
Fast Service | Press Reports |

Copyright LIG © 2016/17 Locum International Inc. All Rights Reserved.
Read our Terms & Conditions of Use
- |

TEL MESSAGE: 24 x 7 - | - - +1-561-865-6147- |



Beware of unauthorized mirror sites - Alway contact IAGIM direct by email